Novartis Investigative Site

Recife 50040-000

0 studies enrolling now · 2 studies all time

What they study most

Acute Heart Failure, Early Breast Cancer

Studies at this site

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Global Non-interventional Heart Failure Disease Registry — Stopped early